0Suppliers
0Customers
3Debt Items
20Related Chains

XOMA Royalty Corporation Suppliers

No suppliers on recordXOMA Royalty Corporation has not yet been matched to upstream suppliers in our database, or is still being processed.

XOMA Royalty Corporation Customers

No clients on recordNo downstream customers found in our database for XOMA Royalty Corporation.

XOMA Royalty Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
XOMAP-DEBT Debt stack $124.7M 90% Market cache reports total debt of $124.7M.
XOMAP-DEBT-13675 Warrants outstanding: 19426 90% xbrl warrant detail from xbrl 2023-12-31.
XOMAP-DEBT-13676 Xbrl Convertible 90% xbrl convertible detail from xbrl 2011-12-31.

XOMA Royalty Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for XOMA Royalty Corporation.

XOMA Royalty Corporation Ownership

HolderNameConfidenceEvidence
XOMAP-OWNER-BVF-INC-IL BVF INC/IL 90% 13F overlay lists BVF INC/IL as top holder; 74 tracked holders.

XOMA Royalty Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
GDTC CytoMed Therapeutics Limited 100.00 2
ELUT Elutia Inc. 100.00 2
ARTV Artiva Biotherapeutics, Inc. 100.00 2
CLLS Cellectis S.A. 100.00 2
AGEN Agenus Inc. 100.00 2
DB Deutsche Bank Aktiengesellschaft 100.00 2
VKTX Viking Therapeutics, Inc. 100.00 2
ACET Adicet Bio, Inc. 100.00 2
AXSM Axsome Therapeutics, Inc. 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
CLYM Climb Bio, Inc. 100.00 2
BBIO BridgeBio Pharma, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
TBPH Theravance Biopharma, Inc. 100.00 2
SUPN Supernus Pharmaceuticals, Inc. 100.00 2
GRAL GRAIL, Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
CRMD CorMedix Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
HOWL Werewolf Therapeutics, Inc. 100.00 2